PTTG1IP and chronic myelogenous leukemia, BCR-ABL1 positive: In conclusion, we have demonstrated that the analysis of ESPL1, PTTG1 and PTTG1IP gene expression levels by qRT-PCR in the peripheral blood of patients at the time of ID can contribute to an early individualized TKI therapy in CML.